GLGary M. Leong

Gary M. Leong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gary M. Leong has a total of 336 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevalence and Risk Factors of Autoimmune Thyroid and Coeliac Disease in Type 1 Diabetes Children and Adolescents; A Retrospective Cohort Analysis

    by William Lau, Shobhit Niraula, Anthony Liu, Gary M. Leong

    Aim: To determine the prevalence and risk factors for autoimmune thyroiditis (AITD) and coeliac disease (CD) in a T1D paediatric and adolescent population.Methods: This was a retrospective cohort analysis of 300 children and adolescents attending a diabetes outpatient clinic from 2017 to 2023. Screening for AITD and CD was done every 1 to 2 years after diagnosis of T1D. Chi‐square analysis and logistic regression models were used to analyse clinical differences between T1D and AITD/CD.Results: The prevalence of AITD and CD in the cohort was 7.7% (n = 23) and 9.3% (n = 28) respectively. Higher rates of AITD were associated with female sex (p = 0.002) and having an additional autoimmune disease (p = 0.05). Subgroup analysis showed that Hashimoto's thyroiditis was associated with female sex (p = 0.02) while Graves' disease was associated with having an additional autoimmune disease (p = 0.047). Patients with AITD also had a lower mean height (p = 0.02) and higher BMI (p = 0.002) than patients without AITD. No significant differences were found in patients with CD. Female sex was associated with higher rates of having both AITD and CD (p = 0.01). Age of T1D onset, diabetic ketoacidosis, or autoimmune family history were not associated with either AITD or CD.Conclusions: Our study showed that the prevalence of autoimmune diseases in T1D remains high, with more cases of CD compared to AITD in our paediatric cohort. Our study suggests that regular screening for AITD and CD in T1D patients remains important and should continue to occur after the detection of one autoimmune disease.


  • Open Access

    The Incidence and Severity of Paediatric Diabetic Ketoacidosis Presenting to a Metropolitan Hospital in Western Sydney

    by Shahzad Sarwar, Gary Leong, Anthony Liu, Habib Bhurawala

    Objectives. To report the incidence and clinical characteristics of paediatric patients presenting with diabetic ketoacidosis to the Emergency Department (ED) with new and pre-existing type 1 diabetes mellitus (T1DM). Methodology. A ten-year retrospective data analysis was performed on children under 16 years presenting to the ED with T1DM from January 2010. Demographic and laboratory data were extracted to determine the rates of DKA. Comparative statistics were performed between age groups and pre-existing and newly diagnosed T1DM patients. Results. A total of 196 children with T1DM were included. The mean age of the cohort was 9.3 ± 4.0 years, with female predominance (54%, p = 0.38). Most (60%) were newly diagnosed with T1DM, of which 38% presented in DKA. Amongst the total cohort, 43% presented in DKA. The older children accounted for 50% of the DKA presentations in the newly diagnosed cohort. Amongst the younger age group, 42% presented with severe DKA. There were higher rates of T1DM in areas of relative socioeconomic advantage. Conclusion. Children with T1DM presented with unacceptably high rates of DKA and posed a significant medical, psychosocial and financial burden on families and medical services. These findings suggest that a prospective public health campaign to reduce rates of DKA is warranted.

  • Slow growth and short stature in children with attention deficit hyperactivity disorder (ADHD): a retrospective study of 493 children who underwent growth hormone provocation testing at one tertiary paediatric endocrine centre

    by Vallimayil Velayutham, Suparna Chakrabarty, Ristan Greer, Andrew M. Cotterill, Gary M. Leong

    Objectives: We hypothesised that growth hormone (GH) deficiency (GHD) in children with attention deficit hyperactivity disorder (ADHD) is rare. This study aimed to determine any distinct clinical or biochemical parameters, including GH provocation testing, in children with ADHD on psychostimulants or idiopathic short stature (ISS). Methods: Retrospective cross-sectional study of children who had GH provocative testing between 1998 and 2013 at one tertiary paediatric endocrine centre. Clinical data included age, sex, anthropometry, pubertal staging, bone age, diagnostic code as per the European Society Paediatric Endocrinology (ESPE), GH provocation test results, thyroid function tests, serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor-binding protein-3 (IGFBP-3) levels. Results: Four hundred ninety-three subjects underwent GH provocation testing for investigation of short stature to exclude GHD during the study period. Fifty-one children had a diagnosis of ADHD. In the remaining children, the diagnosis was Idiopathic short stature (n=240), GHD +/− hypopituitarism (n=60), and 142 subjects had other causes of short stature. Children with ADHD were older, had higher height and weight SDS and were GH-sufficient. All 51 children with ADHD had a normal serum IGFBP-3, while 20 out of these 51 subjects had a low serum IGF-1. Conclusions: GHD in children with ADHD on psychostimulant medication is rare. GH testing in children with ADHD may not be necessary, particularly if serum IGFBP-3 is in the normal range. We suggest IGFBP-3 could be used as a surrogate marker of GH sufficiency in children with ADHD. However, this needs to be confirmed with a larger study group.


  • Open Access

    Paediatric obesity diagnosis and intervention practices in Australian hospitals – Australia‐wide survey

    by Linnette M Ocariza, Gary M Leong, Sowmya Gandham, Alison Poulton, Anthony Liu, Habib Bhurawala

    Aim: Previous studies suggest a lack of a unified approach in identifying and addressing children with obesity while being inpatients in individual Australian hospitals. Our study aimed to describe current clinical practice across Australia and identify discrepancies that can aid in developing a more unified response to children identified with obesity as hospital inpatients.Methods: A cross‐sectional exploratory online survey was distributed to major paediatric in‐patient departments in Australia, with a response rate of 68%. Questions focused on education, identification, interventions and attitudes towards a national protocol.Results: Twenty percent of respondents indicated that staff in their department regularly record body mass index, 66% address weight issues and only 8% consistently refer to appropriate outpatient services. Although 88% of respondents believe that a national protocol for addressing paediatric obesity would be beneficial, respondents emphasised concerns regarding their local resources.Conclusion: Our study can inform the development of a guideline for a unified response to opportunistically identify children with overweight and obesity as inpatients.


  • Open Access

    An Uncommon Presentation of Hamman’s Syndrome in an Adolescent With Acute Diabetic Ketoacidosis and Newly Diagnosed Type 1 Diabetes

    by Daliya George, Malini Rajandran, Habib Bhurawala, Gary M. Leong

    Hamman’s syndrome, a rare complication of diabetic ketoacidosis (DKA), is characterized by subcutaneous emphysema and spontaneous pneumomediastinum. This case report discusses the occurrence of Hamman’s syndrome in an 11‐year‐old adolescent male newly diagnosed with type 1 diabetes mellitus (T1DM) and presenting with severe DKA. The patient exhibited symptoms typical of DKA, including polydipsia, polyuria, abdominal pain, and fatigue, alongside signs such as dehydration, Kussmaul breathing, and tachycardia. Following initial management with intravenous fluids and insulin infusion, he was transferred to a tertiary children’s hospital for further care. Subsequently, on routine examination, he exhibited bilateral neck crepitus and a mediastinal crunching sound on auscultation, indicative of Hamman’s syndrome. Conservative management led to symptom resolution, and the patient was discharged with follow‐up arranged. This case highlights the importance of recognizing Hamman’s syndrome as a potential complication of DKA in pediatric patients. Prompt diagnosis and management, along with differentiation from more severe conditions like Boerhaave’s syndrome, are crucial for ensuring favorable outcomes. Further awareness and understanding of this rare syndrome are essential for optimal patient care and management.


  • Open Access

    Whole exome sequencing reveals copy number variants in individuals with disorders of sex development

    by Rajini Sreenivasan, Katrina Bell, Jocelyn van Den Bergen, Gorjana Robevska, Daniele Belluoccio, Rachana Dahiya, Gary M. Leong, Jérôme Dulon, Philippe Touraine, Elena J. Tucker, et al.


  • Effect of High Intensity Interval Training on Cardiac Function in Children with Obesity: A Randomised Controlled Trial

    by Charlotte B. Ingul, Katrin A. Dias, Arnt E. Tjonna, Turid Follestad, Mansoureh S. Hosseini, Anita S. Timilsina, Siri M. Hollekim-Strand, Torstein B. Ro, Peter S.W. Davies, Peter A. Cain, et al.


  • Effect of High-Intensity Interval Training on Fitness, Fat Mass and Cardiometabolic Biomarkers in Children with Obesity: A Randomised Controlled Trial

    by Katrin A. Dias, Charlotte B. Ingul, Arnt E. Tjønna, Shelley E. Keating, Sjaan R. Gomersall, Turid Follestad, Mansoureh S. Hosseini, Siri M. Hollekim-Strand, Torstein B. Ro, Margrete Haram, et al.

    Background Paediatric obesity significantly increases the risk of developing cardiometabolic diseases across the lifespan. Increasing cardiorespiratory fitness (CRF) could mitigate this risk. High-intensity interval training (HIIT) improves CRF in clinical adult populations but the evidence in paediatric obesity is inconsistent. Objectives The objectives of this study were to determine the efficacy of a 12-week, HIIT intervention for increasing CRF and reducing adiposity in children with obesity. Methods Children with obesity (n = 99, 7–16 years old) were randomised into a 12-week intervention as follows: (1) HIIT [n = 33, 4 × 4-min bouts at 85–95% maximum heart rate (HRmax), interspersed with 3 min of active recovery at 50–70% HRmax, 3 times/week] and nutrition advice; (2) moderate-intensity continuous training (MICT) [n = 32, 44 min at 60–70% HRmax, 3 times/week] and nutrition advice; and (3) nutrition advice only (nutrition) [n = 34]. CRF was quantified through a maximal exercise test (\( \dot{V}{\text{O}}_{{2_{\text{peak}} }} \)) while adiposity was assessed using magnetic resonance imaging (MRI), dual-energy X-ray absorptiometry (DXA) and air-displacement plethysmography. Results HIIT stimulated significant increases in relative \( \dot{V}{\text{O}}_{{2_{\text{peak}} }} \) compared with MICT (+3.6 mL/kg/min, 95% CI 1.1–6.0, P = 0.004) and the nutrition intervention (+5.4 mL/kg/min, 95% CI 2.9–7.9, P = 0.001). However, the intervention had no significant effect on visceral and subcutaneous adipose tissue, whole body composition or cardiometabolic biomarkers (P > 0.05). Conclusion A 12-week, HIIT intervention was highly effective in increasing cardiorespiratory fitness when compared with MICT and nutrition interventions. While there were no concomitant reductions in adiposity or blood biomarkers, the cardiometabolic health benefit conferred through increased CRF should be noted. Clinical trials registration number Clinicaltrials.gov; NCT01991106.


  • Left ventricular morphology and function in adolescents: Relations to fitness and fatness

    by Katrin A. Dias, Angela L. Spence, Satyam Sarma, David Oxborough, Anita S. Timilsina, Peter S.W. Davies, Peter A. Cain, Gary M. Leong, Charlotte B. Ingul, Jeff S. Coombes


  • Top Cited Papers
    Open Access

    Disorders of sex development: insights from targeted gene sequencing of a large international patient cohort

    by Stefanie Eggers, Simon Sadedin, Jocelyn A. van Den Bergen, Gorjana Robevska, Thomas Ohnesorg, Jacqueline Hewitt, Luke Lambeth, Aurore Bouty, Ingrid M. Knarston, Tiong Yang Tan, et al.

    Disorders of sex development (DSD) are congenital conditions in which chromosomal, gonadal, or phenotypic sex is atypical. Clinical management of DSD is often difficult and currently only 13% of patients receive an accurate clinical genetic diagnosis. To address this we have developed a massively parallel sequencing targeted DSD gene panel which allows us to sequence all 64 known diagnostic DSD genes and candidate genes simultaneously. We analyzed DNA from the largest reported international cohort of patients with DSD (278 patients with 46,XY DSD and 48 with 46,XX DSD). Our targeted gene panel compares favorably with other sequencing platforms. We found a total of 28 diagnostic genes that are implicated in DSD, highlighting the genetic spectrum of this disorder. Sequencing revealed 93 previously unreported DSD gene variants. Overall, we identified a likely genetic diagnosis in 43% of patients with 46,XY DSD. In patients with 46,XY disorders of androgen synthesis and action the genetic diagnosis rate reached 60%. Surprisingly, little difference in diagnostic rate was observed between singletons and trios. In many cases our findings are informative as to the likely cause of the DSD, which will facilitate clinical management. Our massively parallel sequencing targeted DSD gene panel represents an economical means of improving the genetic diagnostic capability for patients affected by DSD. Implementation of this panel in a large cohort of patients has expanded our understanding of the underlying genetic etiology of DSD. The inclusion of research candidate genes also provides an invaluable resource for future identification of novel genes.